Page 2044 - Williams Hematology ( PDFDrive )

2018 Part XII: Hemostasis and Thrombosis Chapter 117: Thrombocytopenia 2019

56. Balduini CL, Pecci A, Noris P: Diagnosis and management of inherited thrombocy- 91. Lusher JM, Iyer R: Idiopathic thrombocytopenic purpura in children. Semin Thromb
topenias. Semin Thromb Hemost 39:161–171, 2015. Hemost 3:175–199, 1977.
57. Harrison P, Mackie I, Mumford A, et al: Guidelines for the laboratory investigation of 92. Stasi R, Newland AC: ITP: A historical perspective. Br J Haematol 153:450, 2011.
heritable disorders of platelet function. Br J Haematol 155:30–44, 2011. 93. Frank E: Die essentielle Thrombopenie (Konstitutionelle Purpura-Pseudoha mophilie).
58. Sandoval C, Berger E, Ozkaynak MF: Severe iron deficiency anemia in forty-two pedi- Berl Klin Wochenschr 52:454, 1915.
atric patients. Pediatr Hematol Oncol 19:157–161, 2002. 94. Dameshek W, Miller EB: The megakaryocytes in idiopathic thrombocytopenic pur-
59. Kadikoylu G, Yavasoglu I, Bolaman Z, Senturk T: Platelet parameters in women with pura, a form of hypersplenism. Blood 1:27–50, 1946.
iron deficiency anemia. J Natl Med Assoc 98:398–402, 2006. 95. Harrington WJ, Minnich V, Hollingsworth JW, Moore CV: Demonstration of a throm-
60. Stabler SP, Allen RH, Savage DG, Lindenbaum J: Clinical spectrum and diagnosis of bocytopenic factor in the blood of patients with thrombocytopenic purpura. J Lab Clin
cobalamin deficiency. Blood 76:871–881, 1990. Med 38:1–10, 1951.
61. Sarode R, Garewal G, Marwaha N, et al: Pancytopenia in nutritional megaloblastic 96. Altman LK: Black and blue at the flick of a feather, in Who goes first?, pp 273–282.
anaemia. A study from north-west India. Trop Geogr Med 41:331–336, 1989. Random House, New York, 1987.
62. Slichter SJ, Harker LA: Thrombocytopenia: Mechanisms and management of defects in 97. Shulman NR, Weinrach RS, Libre EP, Andrews HL: The role of the reticuloendothelial
platelet production. Clin Haematol 7:523–539, 1978. system in the pathogenesis of idiopathic thrombocytopenic purpura. Trans Assoc Am
63. Epstein RD: Cells of the megakaryocyte series in pernicious anemia; in particular, the Physicians 78:374–390, 1965.
effect of specific therapy. Am J Pathol 25:239–251, 1949. 98. McMillan R, Smith RS, Longmire RL, et al: Immunoglobulins associated with human
64. Rabinowitz AP, Sacks Y, Carmel R: Autoimmune cytopenias in pernicious anemia: A platelets. Blood 37:316–322, 1971.
report of four cases and review of the literature. Eur J Haematol 44:18–23, 1990. 99. Dixon R, Rosse W, Ebbert L: Quantitative determination of antibody in idiopathic
65. Junca J, Flores A, Granada ML, et al: The relationship between idiopathic thrombocy- thrombocytopenic purpura. Correlation of serum and platelet-bound antibody with
topenic purpura and pernicious anaemia. Br J Haematol 111:513–516, 2000. clinical response. N Engl J Med 292:230–236, 1975.
66. Dittmar M, Kahaly GJ: Polyglandular autoimmune syndromes: Immunogenetics and 100. van Leeuwen EF, van der Ven JT, Engelfriet CP, von dem Borne AE: Specificity of auto-
long-term follow-up. J Clin Endocrinol Metab 88:2983–2992, 2003. antibodies in autoimmune thrombocytopenia. Blood 59:23–26, 1982.
67. Ingeberg S, Stoffersen E: Platelet dysfunction in patients with vitamin B deficiency. 101. McMillan R, Tani P, Millard F, et al: Platelet-associated and plasma anti-glycoprotein
12
Acta Haematol 61:75–79, 1979. autoantibodies in chronic ITP. Blood 70:1040–1045, 1987.
68. Terade H, Niikura H, Mori H, et al: [Megaloblastic anemia and platelet function—a 102. Kiefel V, Santoso S, Weisheit M, Mueller-Eckhardt C: Monoclonal antibody–specific
qualitative platelet defect in pernicious anemia] [in Japanese]. Rinsho Ketsueki 31: immobilization of platelet antigens (MAIPA): A new tool for the identification of plate-
254–255, 1990. let-reactive antibodies. Blood 70:1722–1726, 1987.
69. Green P: Anemias beyond B and iron deficiency: The buzz about other B’s elementary, 103. Kiefel V, Santoso S, Kaufmann E, Mueller-Eckhardt C: Autoantibodies against platelet
12
and nonelementary problems. Hematology Am Soc Hematol Educ Program 2012:498, glycoprotein Ib/IX: A frequent finding in autoimmune thrombocytopenic purpura. Br
2012. J Haematol 79:256–262, 1991.
70. Agnotti LB, Post GR, Robinson NS, et al: Pancytopenia with myelodysplasia due to 104. He R, Reid DM, Jones CE, Shulman NR: Spectrum of Ig classes, specificities, and titers
copper deficiency. Pediatr Blood Cancer 51:693–695, 2008. of serum antiglycoproteins in chronic idiopathic thrombocytopenic purpura. Blood
71. Ballard HS: The hematological complications of alcoholism. Alcohol Health Res World 83:1024–1032, 1994.
21:45–52, 2015. 105. Mueller-Eckhardt C, Mueller-Eckhardt G, Kayser W, et al: Platelet associated IgG,
72. Haselager EM, Vreeken J: Rebound thrombocytosis after alcohol abuse: A possible fac- platelet survival, and platelet sequestration in thrombocytopenic states. Br J Haematol
tor in the pathogenesis of thromboembolic disease. Lancet 1:774–775, 1977. 52:49–58, 1982.
73. Ballard HS: The hematological complications of alcoholism. Alcohol Health Res World 106. Kelton JG, Powers PJ, Carter CJ: A prospective study of the usefulness of the mea-
21:42–52, 2015. surement of platelet-associated IgG for the diagnosis of idiopathic thrombocytopenic
74. Michot F, Gut J: Alcohol-induced bone marrow damage. A bone marrow study in alco- purpura. Blood 60:1050–1053, 1982.
hol-dependent individuals. Acta Haematol 78:252–257, 1987. 107. McMillan R: Autoantibodies and autoantigens in chronic immune thrombocytopenic
75. Latvala J, Parkkila S, Niemela O: Excess alcohol consumption is common in patients purpura. Semin Hematol 37:239–248, 2000.
with cytopenia: Studies in blood and bone marrow cells. Alcohol Clin Exp Res 28:619– 108. Cines DB, Blanchette VS: Immune thrombocytopenic purpura. N Engl J Med 346:995–
624, 2004. 1008, 2002.
76. Sullivan LW, Adams WH, Liu YK: Induction of thrombocytopenia by thrombopheresis 109. Imbach P, Barandun S, d’Apuzzo V, et al: High-dose intravenous gammaglobulin for
in man: Patterns of recovery in normal subjects during ethanol ingestion and absti- idiopathic thrombocytopenic purpura in childhood. Lancet 1:1228–1231, 1981.
nence. Blood 49:197–207, 1977. 110. Hymes K, Schur PH, Karpatkin S: Heavy-chain subclass of round antiplatelet IgG in
77. Smith CM, Tobin JD Jr, Burris SM, White JG: Alcohol consumption in the guinea pig is autoimmune thrombocytopenic purpura. Blood 56:84–87, 1980.
associated with reduced megakaryocyte deformability and platelet size. J Lab Clin Med 111. van der HD, de Jong D, Limpens J, et al: Clonal B-cell populations in patients with
120:699–706, 1992. idiopathic thrombocytopenic purpura. Blood 76:2321–2326, 1990.
78. Wolber EM, Jelkmann W: Thrombopoietin: The novel hepatic hormone. News Physiol 112. Maguire RB, Stroncek DF, Campbell AC: Recurrent pancytopenia, coagulopathy, and
Sci 17:6–10, 2002. renal failure associated with multiple quinine-dependent antibodies. Ann Intern Med
79. Hoffman R: Acquired pure amegakaryocytic thrombocytopenic purpura. Semin Hematol 119:215–217, 1993.
28:303–312, 1991. 113. Liu B, Zhao H, Poon MD: Abnormality of CD4(+)CD25(+) regulatory T cells in idio-
80. Antonijevic N, Terzic T, Jovanovic V, et al: [Acquired amegakaryocytic thrombocytope- pathic thrombocytopenic purpura. Eur J Haematol 78:139–143, 2007.
nia: Three case reports and a literature review] [in Serbian]. Med Pregl 57:292–297, 114. Stasi R, Pagano A, Stipa E, Amadori S: Rituximab chimeric anti-CD20 monoclonal
2004. antibody treatment for adults with chronic idiopathic thrombocytopenic purpura.
81. Dewulf G, Gouin I, Pautas E, et al: [Myelodisplasic syndromes diagnosed in a geriat- Blood 98:952–957, 2001.
ric hospital: Morphological profile in 100 patients]. Ann Biol Clin (Paris) 62:197–202, 115. McKenzie CG, Guo L, Freedman J, Semple JW: Cellular immune dysfunction in
2004. immune thrombocytopenia (ITP). Br J Haematol 163:10–23, 2013.
82. Rochant H: [Myelodysplastic syndromes: Unusual and mild forms] [in French]. Pathol 116. Zhang F, Chu X, Wang L, et al: Cell-mediated lysis of autologous platelets in chronic
Biol (Paris) 45:579–586, 1997. idiopathic thrombocytopenic purpura. Eur J Haematol 76:427–431, 2006.
83. Kini J, Khadilkar UN, Dayal JP: A study of the haematologic spectrum of myelodysplas- 117. Li S, Wang L, Zhao C, et al: CD8+ T cells suppress autologous megakaryocyte apoptosis
tic syndrome. Indian J Pathol Microbiol 44:9–12, 2001. in idiopathic thrombocytopenic purpura. Br J Haematol 139:605–611, 2007.
84. Nand S, Godwin JE: Hypoplastic myelodysplastic syndrome. Cancer 62:958–964, 1988. 118. Hauch TW, Rosse WF: Platelet-bound complement (C3) in immune thrombocytope-
85. Zafar T, Yasin F, Anwar M, Saleem M: Acquired amegakaryocytic thrombocytopenic nia. Blood 50:1129–1136, 1977.
purpura (AATP): A hospital based study. J Pak Med Assoc 49:114–117, 1999. 119. Kurata Y, Curd JG, Tamerius JD, McMillan R: Platelet-associated complement in
86. Nagasawa T, Sakurai T, Kashiwagi H, Abe T: Cell-mediated amegakaryocytic thrombo- chronic ITP. Br J Haematol 60:723–733, 1985.
cytopenia associated with systemic lupus erythematosus. Blood 67:479–483, 1986. 120. Tsubakio T, Tani P, Curd JG, McMillan R: Complement activation in vitro by antiplatelet
87. Slater LM, Katz J, Walter B, Armentrout SA: Aplastic anemia occurring as amegakaryo- antibodies in chronic immune thrombocytopenic purpura. Br J Haematol 63:293–300,
cytic thrombocytopenia with and without an inhibitor of granulopoiesis. Am J Hematol 1986.
18:251–254, 1985. 121. Verschoor A, Langer HF: Crosstalk between platelets and the complement system in
88. Shiozaki H, Miyawaki S, Kuwaki T, et al: Autoantibodies neutralizing thrombopoietin immune protection and disease. Thromb Haemost 110:910–919, 2013.
in a patient with amegakaryocytic thrombocytopenic purpura. Blood 95:2187–2188, 122. Aster RH, Keene WR: Sites of platelet destruction in idiopathic thrombocytopenic pur-
2000. pura. Br J Haematol 16:61–73, 1969.
89. Katsumata Y, Suzuki T, Kuwana M, et al: Anti-c-Mpl (thrombopoietin receptor) auto- 123. Ballem PJ, Segal GM, Stratton JR, et al: Mechanisms of thrombocytopenia in chronic
antibody-induced amegakaryocytic thrombocytopenia in a patient with systemic scle- autoimmune thrombocytopenic purpura. Evidence of both impaired platelet produc-
rosis. Arthritis Rheum 48:1647–1651, 2003. tion and increased platelet clearance. J Clin Invest 80:33–40, 1987.
90. Leach JW, Hussein KK, George JN: Acquired pure megakaryocytic aplasia report of 124. Chang M, Nakagawa PA, Williams SA, et al: Immune thrombocytopenic purpura (ITP)
two cases with long-term responses to antithymocyte globulin and cyclosporine. Am J plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in
Hematol 62:115–117, 1999. vitro. Blood 102:887–895, 2003.

Kaushansky_chapter 117_p1993-2024.indd 2019 9/21/15 2:34 PM